CytoDyn Inc. Files 8-K on Shareholder Votes
Ticker: CYDY · Form: 8-K · Filed: Nov 22, 2024 · CIK: 1175680
| Field | Detail |
|---|---|
| Company | Cytodyn Inc. (CYDY) |
| Form Type | 8-K |
| Filed Date | Nov 22, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, 8-k
Related Tickers: CYDY
TL;DR
CYDY filed an 8-K for shareholder votes - standard governance stuff.
AI Summary
CytoDyn Inc. filed an 8-K on November 22, 2024, to report on matters submitted to a vote of its security holders. The filing details the company's corporate structure, including its incorporation in Delaware and its fiscal year end of May 31. The report does not contain specific details about the voting matters or any financial transactions.
Why It Matters
This filing indicates that CytoDyn Inc. is engaging in corporate governance processes requiring shareholder approval, which is a standard but important aspect of public company operations.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding shareholder votes and does not present immediate financial or operational risks.
Key Players & Entities
- CytoDyn Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- November 22, 2024 (date) — Date of report
FAQ
What specific matters were submitted to a vote of CytoDyn Inc. security holders?
The filing states that it is a report on 'Submission of Matters to a Vote of Security Holders' but does not specify the exact proposals voted upon in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported is November 22, 2024, which is also the date of the report.
In which state is CytoDyn Inc. incorporated?
CytoDyn Inc. is incorporated in Delaware.
What is CytoDyn Inc.'s fiscal year end?
CytoDyn Inc.'s fiscal year ends on May 31.
What is the principal executive office address for CytoDyn Inc.?
The principal executive office is located at 1111 Main Street, Suite 660, Vancouver, Washington 98660.
Filing Stats: 542 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-11-22 17:15:35
Filing Documents
- cydy-20241122x8k.htm (8-K) — 53KB
- 0001558370-24-015918.txt ( ) — 180KB
- cydy-20241122.xsd (EX-101.SCH) — 3KB
- cydy-20241122_lab.xml (EX-101.LAB) — 17KB
- cydy-20241122_pre.xml (EX-101.PRE) — 12KB
- cydy-20241122x8k_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. CytoDyn Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting") on November 22, 2024. On November 22, 2024, the Inspector of Election issued its final report certifying the final voting results for the Annual Meeting, which were as follows: 1. Election of Directors. Nominee For Withheld Broker Non-Votes Tanya Durkee Urbach 324,668,950 62,148,477 247,674,869 Stephen M. Simes 359,999,216 24,818,211 247,674,869 Ryan M. Dunlap 362,080,939 24,736,488 247,674,869 Lishomwa C. Ndhlovu, M.D., Ph.D. 360,175,478 26,641,949 247,674,869 Karen J. Brunke, Ph.D. 360,021,777 26,795,650 247,674,869 The stockholders elected each of the Company's director nominees to serve until the Company's 2025 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. 2. Ratification of Appointment of Independent Registered Public Accounting Firm For Against Abstentions Broker Non-Votes 619,778,908 9,126,390 5,586,998 -0- The stockholders voted to ratify the selection of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending May 31, 2025. 3. Advisory vote on compensation of named executive officers. For Against Abstentions Broker Non-Votes 315,973,038 63,214,010 7,630,379 247,674,869 The stockholders approved, on an advisory basis, the compensation paid to the Company's named executive officers. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CYTODYN INC. Date: November 22, 2024 By /s/ Tyler Blok Tyler Blok Chief Legal Officer and Corporate Secretary